Has Steven Davison, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,796 in general payments to Steven Davison, MD across 102 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Davison, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Davison, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Davison, MD

Plastic and Reconstructive Surgery · Washington, DCNPI 1003814062

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,096 of the $6,796 with a category attached, or 60.3%. 15 manufacturers reported payments, led by AbbVie at 58.3% of the total. Reporting peaked in 2019 at $3,282 and has fallen 80.7% since, to $633 in 2025.

$6,796in general payments, 2019–2025

Across 102 payments — averaging $66.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$4K
Mentor Worldwide LLC$984
Integra Lifesciences Corporation$548
Bard Peripheral Vascular, Inc.$277
Axogen$198
Galderma Laboratories, L.p.$186
plus $644 from 9 others

$16,648in research payments, 2019–2025

Across 10 payments — averaging $1664.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$17K

What the payments were for

Food & beverage$4,09660%
Gifts$2,70040%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	53	$3,959
Mentor Worldwide LLC	14	$984
Integra Lifesciences Corporation	6	$548
Bard Peripheral Vascular, Inc.	4	$277
Axogen	4	$198
Galderma Laboratories, L.p.	9	$186
TELA Bio, Inc.	2	$181
Smith+Nephew	1	$139
Motiva USA, LLC	2	$107
Innovation Technologies Inc	1	$88
Pacira Pharmaceuticals Incorporated	2	$43
Davol Inc.	1	$29
Vertex	1	$25
Solta Medical, A Division Of Bausch Health US, LLC	1	$21
Stryker	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NATRELLE$2,960
INTEGRA$523
MENTOR SILTEX Round SPECTRUM$306
ARTOURA Breast Tissue Expander$300
MENTOR CPX 2 Breast Tissue Expander$256
GalaFLEX$247
TENOGLIDE$181
MENTOR MemoryGel Resterilizable Gel Sizer$175
INTEGRA DERMAL REGENERATION TEMPLATE$174
PRIMATRIX$174
GRAFIX PL$139
Stravix$139
AVANCE NERVE GRAFT$121
OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$119
NATRELLE SALINE-FILLED BREAST IMPLANTS$103

How this compares

Too few plastic and reconstructive surgery providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$90,476

Medicare patients

Services billed

383

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	19	$156
Ibuprofen	30	$103
Gabapentin	12	$65
Cefadroxil	12	$53
Ondansetron Hcl	22	$44

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Washington

David SongWashington$968K
Troy PittmanWashington$153K
Christopher AttingerWashington$30K
Stephen BakerWashington$8K
Daniel TranWashington$3K
Jerry ChaoWashington$3K
Ivica DucicWashington$1K
Paul MartinezWashington$835
Michael BoyajianWashington$577
Steven HoppingWashington$529

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →